Oracle unveiled Oracle Health Sciences Trial Center, a gateway application that delivers a unified view of actionable real-time information across multiple trials, sites and systems and provides direct access to relevant trial technologies.
The solution enables health sciences organizations and contract research organizations (CROs) to maximize productivity of study managers, coordinators and monitors, while strengthening collaboration and relationships between sponsors, sites, and partners.Today, many eClinical technology users struggle to prioritize and manage tasks across a complex environment of systems spanning multiple clinical trials. Oracle Health Sciences Trial Center offers a new approach to addressing this challenge by providing a single console for users to access real-time clinical trial progress summaries and task priorities across all trials.
Oracle Health Sciences Trial Center aims to simplify the completion of daily tasks related to clinical trials by presenting a comprehensive and role-based view of the information and actions required to accelerate clinical trials. For example, a data manager can view data discrepancies across multiple trials at once and manage the discrepancies from a single interface, eliminating time spent toggling through multiple applications and reducing the potential for error.
In addition, by aggregating relevant information from multiple sources in real-time, Oracle Health Sciences Trial Center provides a bird’s-eye view that enables users to compare information and metrics across trials or sites to gain insight into areas for improvement or causes for concern. As a result, users can optimize work planning and execution across all trials without entering multiple studies and applications.
Oracle Health Sciences Trial Center allows users to drill down into the information and to directly access specific trial applications with a single click if more detail or action is required. The solution also helps to strengthen relationships and collaboration between sponsors, sites, and other partners, such as CROs, by providing all parties with a common and transparent view of trial priorities, progress and activities.
Oracle Health Sciences Trial Center is part of a comprehensive portfolio of Oracle Health Sciences Cloud Applications and is powered by the Oracle Health Sciences Cloud to help customers accelerate IT deployments, reduce resources required to maintain IT infrastructure and gain a more predictable IT spending pattern.
QWINT-1 Trial: Once-Weekly Efsitora Matches Daily Glargine in Type 2 Diabetes Management
July 10th 2025Results from the Phase III QWINT-1 trial show that Eli Lilly’s once-weekly insulin efsitora is noninferior to once-daily glargine in reducing HbA1c among insulin-naïve adults with type 2 diabetes, offering a simplified fixed-dose regimen with fewer hypoglycemic events and less treatment burden.
Unifying Industry to Better Understand GCP Guidance
May 7th 2025In this episode of the Applied Clinical Trials Podcast, David Nickerson, head of clinical quality management at EMD Serono; and Arlene Lee, director of product management, data quality & risk management solutions at Medidata, discuss the newest ICH E6(R3) GCP guidelines as well as how TransCelerate and ACRO have partnered to help stakeholders better acclimate to these guidelines.
FDA Expands Farapulse PFA Approval to Persistent AF After Strong ADVANTAGE AF Trial Results
July 7th 2025Boston Scientific’s Farapulse Pulsed Field Ablation System is now approved for treating persistent atrial fibrillation, following 12-month data from the ADVANTAGE AF trial showing strong safety, high freedom from AF, and no major complications.